ID

19414

Description

NCT01117584 Astellas Phase 2b, Double-Blind, Randomized, Multicenter, Parallel Group, Placebo-Controlled, Dose-Finding Study to Evaluate the Efficacy, Safety and Tolerability of a 12- Week Treatment with ASP1941 in Combination with Metformin in Patients with Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone.

Mots-clés

  1. 30/12/2016 30/12/2016 -
  2. 04/02/2017 04/02/2017 -
Téléchargé le

30 décembre 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

End of Study: End of Treatment/ Premature Discontinuation [DS_1] NCT01117584

End of Study: End of Treatment/ Premature Discontinuation [DS_1] NCT01117584

General Information
Description

General Information

Date of Last Treatment Evaluation Through Visit 7
Description

Date of Collection

Type de données

datetime

Study day of collection
Description

Study day of collection

Type de données

text

Did subject complete Study Drug Treatment?
Description

Complete Study Drug Treatment

Type de données

boolean

If no, please provide details below.
Description

Study Drug Treatment

Type de données

text

End of Treatment
Description

End of Treatment

Type de données

text

If reason is `Withdrawal by Subject` please speficy follow-up allowance
Description

Withdrawal by subject

Type de données

integer

Date of Withdrawal
Description

Date of Withdrawal

Type de données

date

Did AE result in death?
Description

Result in Death

Type de données

text

If "Protocol Violation", please specify
Description

Protocol Violation

Type de données

text

If "Other" please specify
Description

Other

Type de données

text

Similar models

End of Study: End of Treatment/ Premature Discontinuation [DS_1] NCT01117584

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
General Information
Date of Collection
Item
Date of Last Treatment Evaluation Through Visit 7
datetime
Study day of collection
Item
Study day of collection
text
Complete Study Drug Treatment
Item
Did subject complete Study Drug Treatment?
boolean
Study Drug Treatment
Item
If no, please provide details below.
text
Item
End of Treatment
text
Code List
End of Treatment
CL Item
Not fulfill inclusion or exclusion criteria  (1)
CL Item
Adverse event (2)
CL Item
Lack of efficacy (3)
CL Item
Withdrawal by subject (4)
CL Item
Subject lost to follow-up (5)
CL Item
Protocol violation (6)
CL Item
Randomized/registered but never received/dispensed study drug (7)
CL Item
Other (8)
Item
If reason is `Withdrawal by Subject` please speficy follow-up allowance
integer
Code List
If reason is `Withdrawal by Subject` please speficy follow-up allowance
CL Item
Allows follow-up after withdrawal (1)
CL Item
Does not allow follow-up after withdrawal (2)
Date of Withdrawal
Item
Date of Withdrawal
date
Item
Did AE result in death?
text
Code List
Did AE result in death?
CL Item
Yes (1)
CL Item
No (2)
CL Item
Unknown (3)
Protocol Violation
Item
If "Protocol Violation", please specify
text
Other
Item
If "Other" please specify
text

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial